GSK-3α Inhibition in Drug-Resistant CML Cells Promotes Susceptibility to NK Cell-Mediated Lysis in an NKG2D- and NKp30-Dependent Manner. The gene discussed is KLRK1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.